https://asianetnews.net/news/hovione-and-zerion-pharma-announce-a-strategic-partnership-to-market-the-dispersomer-technology-platform/
Hovione and Zerion Pharma announce a strategic partnership to market the Dispersome(R) technology...
Apr 9, 2023 - Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize...
zerion pharmastrategic partnershipto markethovioneannounce
https://manufacturingchemist.com/hovione-expands-nasal-drug-delivery-capabilities
Hovione expands nasal drug delivery capabilities
In collaboration with IDC, the nasal powder delivery device technology provides a good alternative to conventional delivery routes for both local and systemic...
drug deliveryhovioneexpandsnasalcapabilities
https://www.prnewswire.com/news-releases/hovione-and-ht-presspart-extend-partnership-to-advance-high-efficiency-device-technology-for-dry-powder-inhalation-formulation-delivery-301814506.html
Hovione and H&T Presspart extend partnership to advance high efficiency device technology for Dry...
high efficiencyhovioneextendpartnershipadvance
https://www.hovione.com/
Hovione | The specialist integrated CDMO
the specialisthovioneintegratedcdmo
https://www.clinicaltrialsarena.com/news/hovione-trial-meizuvo-dry-eye-disease-mgd/
Hovione completes trial of Meizuvo for dry eye disease caused by MGD
Jul 12, 2022 - Hovione has completed the Phase II trial of Meizuvo for dry eye disease caused by Meibomian Gland Dysfunction (MGD).
dry eye diseasehovionecompletestrialcaused